We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Home Secretary launched the UK's updated counter-terrorism strategy, CONTEST 2023, at Central Hall, Westminster.
First published during the 2022 to 2024 Sunak Conservative government
Upper Tribunal Administrative Appeals Chamber decision by Judge Grey KC on 2 March 2023.
The NDNS Blood Analyte report, published on 27 October 2011, for Years 1 and 2 combined is available at the link at the bottom of this page.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
To improve nutrition in the developing world, new funding will be used to evaluate the evidence and carry out research on what works and what doesn’t.
Upper Tribunal Administrative Appeals Chamber decision by Judge Hemingway on 24 October 2022.
Initiate orlistat treatment only after careful consideration of the possible impact on efficacy of antiretroviral HIV medicines.
The Medicines and Healthcare products Regulatory Agency (MHRA) is working in partnership with Slimming World as part of the Agency’s wider #FakeMeds Campaign to encourage those wanting to lose weight to turn to safe, legitimate and appropriate routes.
Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK: you should only access these medicines via a medical prescription.
Public Health England has today published new data detailing the state of the nation’s diet.
Engaging women through motivational conversations and via a digital platform.
In a New Year with new beginnings, the dangers of fake and unlicensed medical products remain the same. We continue our campaign against fake and unlicensed medical products in 2017.
The tighter controls being introduced to minimise risk of overuse and or addiction of painkillers containing codeine or dihydrocodeine.
First published during the 2019 to 2022 Johnson Conservative government
MHRA are revealing a different fact about the issue of fake and unlicensed medical products every day in December leading up to Christmas.
The government has today launched CONTEST 2023, a refreshed approach to the evolving and enduring threat from terrorism.
Reminder to monitor and manage weight, glucose, and lipid levels.
(ITH Pharma Ltd) Small number of reported cases of bacillus cereus septicaemia affecting neonates - class 1 action now. (EL (14)A/05)
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).